Chlamydia remains one of the most common ... The researchers are now planning to launch a larger, phase 2 trial that would look at the vaccine’s effectiveness. The hope is that one day the ...

A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI). There is currently no ...

A Chlamydia vaccine showed promising results in an early-stage clinical trial conducted by researchers in the U.K. and Denmark. The early phase of the research found the experimental vaccine to be ...

Sanofi’s chlamydia vaccine candidate was designed to protect ... vaccine will be evaluated in an upcoming phase 1/2 clinical trial (ClinicalTrials.gov Identifier: NCT06891417) that will include ...

Scientists have taken a step towards a vaccine for chlamydia following a successful early trial. A vaccine developed by a British and Danish team was shown to be safe and effective during a ...

An investigational vaccine against chlamydia (CTH522) induced neutralizing antibodies in all participants who received it, and with no major safety concerns, results of a phase I trial showed.

An early-stage clinical trial has come back with promising results for a chlamydia vaccine, researchers have said. There is currently no jab to protect against the disease, which is one of the ...

An early-stage clinical trial yielded promising results for a chlamydia vaccine, researchers reported Thursday in The Lancet Infectious Diseases. Chlamydia remains one of the most common causes of ...